Viking Therapeutics

Yahoo Finance • 11 days ago

Eli Lilly Dives 14% On A Shocking Obesity Setback, Sending Its Rivals Flying

Eli Lilly stock tumbled Thursday on an unexpected setback for its obesity franchise, sending shares of its rival flying. Continue Reading View Comments... Full story

Yahoo Finance • 11 days ago

Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors

On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns Pharmaceuticals, Inc. (NASDAQ:TERN), Viking Therapeutics Inc. (NASDAQ:VKTX), and Structure Therapeutics Inc. (NASDAQ... Full story

Yahoo Finance • 11 days ago

Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge.

Eli Lilly stock tumbled Thursday on an unexpected setback for its obesity franchise, sending shares of its rival flying. Continue Reading View Comments... Full story

Yahoo Finance • 11 days ago

Eli Lilly's obesity drug data lifts Viking Therapeutics stock

Investing.com -- Viking Therapeutics (NASDAQ:VKTX) stock rose 11% Thursday after Eli Lilly’s (NYSE:LLY) data on its oral obesity drug orforglipron fell short of investor expectations. Eli Lilly reported that its experimental pill helped p... Full story

Yahoo Finance • 16 days ago

3 Unstoppable Stocks to Buy in August

What are the best stocks? Usually, the ones that have clear paths to success. Three Motley Fool contributors have identified what they believe are unstoppable stocks to buy in August. And they all happen to be biotech and pharma companies... Full story

Yahoo Finance • 18 days ago

PBF Energy declares $0.275 dividend

* PBF Energy (NYSE:PBF [https://seekingalpha.com/symbol/PBF]) declares $0.275/share quarterly dividend [https://seekingalpha.com/pr/20184218-pbf-energy-announces-second-quarter-2025-results-and-declares-dividend-of-0_275-per-share], in l... Full story

Yahoo Finance • 25 days ago

Stocks making the biggest moves premarket: Chipotle, Tesla, ServiceNow, Las Vegas Sands and more

Check out the companies making headlines in premarket trading. Meme stocks — These stocks once again are making attention-grabbing moves. Opendoor Technologies jumped 7%, while GoPro and Krispy Kreme each fell around 4%. Dow Inc. — The che... Full story

Yahoo Finance • 26 days ago

Stocks making the biggest moves after hours: ServiceNow, IBM, Chipotle Mexican Grill and more

Check out the companies making headlines after the bell : T-Mobile — Shares of the mobile telecommunication company jumped more than 4% after its second-quarter earnings topped Wall Street's estimates. T-Mobile reported earnings $2.84 per... Full story

Yahoo Finance • last month

VKTX August 29th Options Begin Trading

Investors in Viking Therapeutics Inc (Symbol: VKTX) saw new options begin trading today, for the August 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VKTX options chain for the new August 29... Full story

Yahoo Finance • 2 months ago

Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?

Protagonist Therapeutics is taking aim directly at Eli Lilly's obesity treatment with a newly announced drug that uses the same mechanism. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

BTIG reiterates buy rating on Viking Therapeutics stock amid obesity trials

Investing.com - BTIG reiterated its Buy rating and $125.00 price target on Viking Therapeutics (NASDAQ:VKTX), currently trading at $26.82, following the company’s announcement of two Phase 3 obesity trials. According to InvestingPro data,... Full story

Yahoo Finance • 2 months ago

Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity

Viking Therapeutics stock remains under pressure, but analysts said Wednesday the company's strategy for its Phase 3 studies could pay off. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

H.C. Wainwright reiterates buy rating on Viking Therapeutic stock

Investing.com - H.C. Wainwright maintained its buy rating and $102.00 price target on Viking Therapeutic (NASDAQ:VKTX) stock on Wednesday, representing significant upside from the current price of $25.96. According to InvestingPro data, an... Full story

Yahoo Finance • 2 months ago

Tesla, Regencell lead market cap stock movers this Monday

Monday’s market has seen significant movements across various stocks, with companies like Tesla Motors (NASDAQ:TSLA) and Regencell Bioscience Holdings (RGC) experiencing notable changes. These intra-day stock movements are driven by a mi... Full story

Yahoo Finance • 2 months ago

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

Key Points These biotech companies have several catalysts ahead -- and in the past have soared on good news. They both offer innovative candidates that could result in game-changing treatments for patients. 10 stocks we like better than V... Full story

Yahoo Finance • 2 months ago

Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?

We recently published a list of Jim Cramer Nailed These 11 Stock Predictions. In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other stocks that Jim Cramer discusses. Back then,... Full story

Yahoo Finance • 3 months ago

3 Best Growth Stocks to Buy in June

Key Points These three growth stocks have major catalysts that could drive significant gains in the months ahead. The selections range from AI infrastructure plays to biotechnology. 10 stocks we like better than CoreWeave › Growth invest... Full story

Yahoo Finance • 3 months ago

Better Weight Loss Stock: Amgen or Viking Therapeutics?

Key Points Amgen's weight loss candidate reported mixed phase 2 data, but the company has other weapons. Viking Therapeutics' leading anti-obesity program aced mid-stage studies, and it's not its only promising candidate. Deciding between... Full story

Yahoo Finance • 3 months ago

Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price

Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition. Continue Reading View Comments... Full story

Yahoo Finance • 3 months ago

3 Monster Stocks in the Making

Key Points Axsome Therapeutics is taking off, led by a treatment for major depressive disorder. Iovance Biotherapeutics could transform how solid tumors are treated. Viking Therapeutics is taking on giants in the obesity drug market. 10 s... Full story